{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:39:04Z","timestamp":1790908744397,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1124\/jpet.122.001419","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T16:15:15Z","timestamp":1673367315000},"page":"353-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder"],"prefix":"10.1016","volume":"384","author":[{"given":"Michelle R.","family":"Doyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey N.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001419_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13168","article-title":"Interactions between impulsivity and MDPV self-administration in rats","volume":"27","author":"Abbott","year":"2022","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.122.001419_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108009","article-title":"Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration","volume":"168","author":"Anastasio","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001419_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tips.2016.11.002","article-title":"Insights from Preclinical Choice Models on Treating Drug Addiction","volume":"38","author":"Banks","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 1","key":"10.1124\/jpet.122.001419_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuropharm.2004.07.007","article-title":"Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats","volume":"47","author":"Barrett","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001419_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145712000661","article-title":"Modification of cocaine self-administration by buspirone (buspar\u00ae): potential involvement of D3 and D4 dopamine receptors","volume":"16","author":"Bergman","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.122.001419_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006205-199211000-00018","article-title":"Extrapyramidal symptoms are serious side-effects of antipsychotic and other drugs","volume":"17","author":"Blair","year":"1992","journal-title":"Nurse Pract"},{"key":"10.1124\/jpet.122.001419_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00213-011-2382-5","article-title":"Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats","volume":"219","author":"Collins","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1037\/pha0000209","article-title":"Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys","volume":"26","author":"Collins","year":"2018","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.122.001419_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2017.12.023","article-title":"The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders","volume":"142","author":"Collins","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001419_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.115.228833","article-title":"Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys","volume":"356","author":"Collins","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib11","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/npp.2011.226","article-title":"Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats","volume":"37","author":"Collins","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001419_bib12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/npp.2014.300","article-title":"Effects of oral and intravenous administration of buspirone on food-cocaine choice in socially housed male cynomolgus monkeys","volume":"40","author":"Czoty","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001419_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fnbeh.2019.00292","article-title":"Dopamine D3 Receptor Antagonism Reverses the Escalation of Oxycodone Self-Administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock Rats","volume":"13","author":"de Guglielmo","year":"2020","journal-title":"Front Behav Neurosci"},{"key":"10.1124\/jpet.122.001419_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)20871-0","article-title":"Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol","volume":"251","author":"De Vry","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1124\/jpet.121.000655","article-title":"Influence of Contingent and Noncontingent Drug Histories on the Development of High Levels of MDPV Self-Administration","volume":"379","author":"Doyle","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12904","article-title":"Interactions between reinforcement history and drug-primed reinstatement: Studies with MDPV and mixtures of MDPV and caffeine","volume":"26","author":"Doyle","year":"2021","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.122.001419_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00213-020-05726-2","article-title":"MDPV self-administration in female rats: influence of reinforcement history","volume":"238","author":"Doyle","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.122.001419_bib19","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001419_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.116.239376","article-title":"Individual Differences in the Relative Reinforcing Effects of 3, 4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats","volume":"361","author":"Gannon","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00213-021-05764-4","article-title":"MDPV \u201chigh-responder\u201d rats also self-administer more oxycodone than their \u201clow-responder\u201d counterparts under a fixed ratio schedule of reinforcement","volume":"238","author":"Gannon","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.117.246082","article-title":"Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin is Mediated by 5-HT2C Receptors in Rats","volume":"364","author":"Gannon","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.116.236307","article-title":"Effects of Lorcaserin on Cocaine and Methamphetamine Self-Administration and Reinstatement of Responding Previously Maintained by Cocaine in Rhesus Monkeys","volume":"359","author":"Gerak","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1037\/pha0000234","article-title":"Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys","volume":"27","author":"Gerak","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.122.001419_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/syn.20152","article-title":"Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors","volume":"57","author":"Gilbert","year":"2005","journal-title":"Synapse"},{"key":"10.1124\/jpet.122.001419_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2015.09.028","article-title":"The 5-HT(2C) receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity","volume":"101","author":"Harvey-Lewis","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001419_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00213-012-2919-2","article-title":"Evaluation of chemically diverse 5-HT2c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles","volume":"226","author":"Higgins","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acschemneuro.6b00444","article-title":"Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101","volume":"8","author":"Higgins","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.122.001419_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/npp.2012.224","article-title":"Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists","volume":"38","author":"Hiranita","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001419_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.122.001419_bib31","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00213-014-3760-6","article-title":"Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm","volume":"232","author":"John","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib32","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1111\/bph.15244","article-title":"(\u00b1)VK4-40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents","volume":"177","author":"Jordan","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001419_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.003","article-title":"The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents","volume":"158","author":"Jordan","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001419_bib34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.259390","article-title":"Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats","volume":"371","author":"Jordan","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/FBP.0000000000000209","article-title":"A role for sigma receptors in stimulant self-administration and addiction","volume":"27","author":"Katz","year":"2016","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.122.001419_bib36","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1021\/jm501512b","article-title":"Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 receptor Hypothesis","volume":"58","author":"Keck","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001419_bib37","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/acs.jmedchem.6b00860","article-title":"Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment","volume":"59","author":"Kumar","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001419_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pbb.2017.06.006","article-title":"Modeling the development of drug addiction in male and female animals","volume":"164","author":"Lynch","year":"2018","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.122.001419_bib39","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00213-020-05732-4","article-title":"Shifts in the neurobiological mechanisms motivating cocaine use with the development of an addiction-like phenotype in male rats","volume":"238","author":"Lynch","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib56","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1124\/jpet.122.001419_bib40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1021\/acschemneuro.6b00413","article-title":"Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats","volume":"8","author":"Neelakantan","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.122.001419_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-pharmtox-030220-124205","article-title":"New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders","volume":"61","author":"Newman","year":"2021","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.122.001419_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00213-010-2058-6","article-title":"A novel IV cocaine self-administration procedure in rats: differential effects of dopamine, serotonin, and GABA drug pre-treatments on cocaine consumption and maximal price paid","volume":"214","author":"Oleson","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/22560","article-title":"Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist","volume":"400","author":"Pilla","year":"1999","journal-title":"Nature"},{"key":"10.1124\/jpet.122.001419_bib44","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1017\/S1461145714000856","article-title":"Effects of the 5-HT2C receptor agonist CP809101 in the amygdala on reinstatement of cocaine-seeking behavior and anxiety-like behavior","volume":"17","author":"Pockros-Burgess","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.122.001419_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopsych.2013.09.028","article-title":"Diminished role of dopamine D1-receptor signaling with the development of an addicted phenotype in rats","volume":"76","author":"Ram\u00f4a","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.122.001419_bib46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41386-018-0292-5","article-title":"NIDA\u2019s medication development priorities in response to the Opioid Crisis: ten most wanted","volume":"44","author":"Rasmussen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001419_bib47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00439560","article-title":"Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment","volume":"97","author":"Roberts","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001419_bib48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.115.228148","article-title":"Directly Observable Behavioral Effects of Lorcaserin in Rats","volume":"355","author":"Serafine","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/clpt.2011.20","article-title":"Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users","volume":"89","author":"Shram","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.122.001419_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuropharm.2006.07.024","article-title":"CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity","volume":"52","author":"Siuciak","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001419_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.117.241141","article-title":"Effects of Acute and Chronic Treatments with Dopamine D2 and D3 Receptor Ligands on Cocaine Versus Food Choice in Rats","volume":"362","author":"Thomsen","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001419_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107848","article-title":"Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys","volume":"208","author":"Townsend","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001419_bib53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41583-020-0378-z","article-title":"Improving translation of animal models of addiction and relapse by reverse translation","volume":"21","author":"Venniro","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.122.001419_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1472-8206.1999.tb00353.x","article-title":"Role of CYP3A in haloperidol N-dealkylation and pharmacokinetics in rats","volume":"13","author":"Watanabe","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.122.001419_bib55","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41386-018-0284-5","article-title":"Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects","volume":"44","author":"You","year":"2019","journal-title":"Neuropsychopharmacology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:28:03Z","timestamp":1739953683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524004087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0022356524004087"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001419","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742490594.793598349","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright.","name":"copyright","label":"Copyright"}]}}